# Radiation Oncology/NSCLC/RTOG Lung

* Front Page: Radiation Oncology | RTOG Trials | Randomized Trials
* RTOG Website
* Wikibooks list of RTOG trials
NSCLC: RTOG OPEN TRIALS :
| Number | Title |
| 09-15 | A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules For Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer |
| 08-13 | Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable Patients |
| 06-18 | A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer |
| 06-17 | A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High Dose (74 Gy) Conformal Radiotherapy With Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444) In Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer |
| 02-29 | A Phase II Trial Of Neoadjuvant Therapy With Concurrent Chemotherapy And High Dose Radiotherapy Followed by Surgical Resection And Consolidative Therapy For Locally Advanced Non-Small Cell Lung Carcinoma |
NSCLC: RTOG CLOSED TRIALS :
| Number | Title | Publication PMID XXXXXXXXXX |
| 05-15 | A Comparative Study Of Gross Tumor Volume Definition With Or Without PET Fusion For Patients With Non-Small Cell Lung Carcinoma | |
| 04-12 | SWOG S0332 Phase III Randomized Trial of Preoperative Chemotherapy Versus Preoperative Concurrent Chemotherapy and Thoracic Radiotherapy Followed by Surgical Resection and Consolidation Chemotherapy in Favorable Prognosis Patients with Stage IIIA (N2) Non-Small Cell Lung Cancer CLOSED - POOR ACCRUAL | |
| 03-24 | A Phase II Study Of Cetuximab (C225) In Combination With Chemoradiation In Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) | chapter link PMID 21555682 |
| 02-36 | A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer | |
| 02-35 | Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Non-small Cell Lung Carcinoma | |
| 02-14 | A Phase III Comparison Of Prophylactic Cranial Irradiation Versus Observation In Patients With Locally Advanced Non-Small Cell Lung Cancer | |
| 02-13 | A Phase I/II Trial of A Cox-2 Inhibitor, Celebrex (Celecoxib), with Limited Field Radiation for Intermediate Prognosis Patients with Locally Advanced Non-Small Cell Lung Cancer, with Analysis of Prognostic Factors CLOSED - ACCRUAL NOT MET | |
| 01-17 01-17 | A Phase I/II Dose Intensification Study using Three Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients with Inoperable, Non-Small Cell Lung Cancer | PMID 20368547 PMID 20457350 |
| 00-17 Clinicaltrials.gov | A Phase I Study Of Gemcitabine, Carboplatin Or Gemcitabine, Paclitaxel And Radiation Therapy Followed By Adjuvant Chemotherapy For Patients With Favorable Prognosis Inoperable Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) | PMID 19096311 |
| 00-15 Clinicaltrials.gov | SWOG S9900 A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non Small Cell Lung Cancer (NSCLC) | PMID 20231678 |
| 99-09 | Phase II Study of Postoperative Adjuvant Immunotherapy and Radiation in Patients with Completely Resected Stage II and Stage IIIA Non-Small Cell Lung Cancer | |
| 98-01 Clinicaltrials.gov | A Phase III Study Of Amifostine Mucosal Protection For Patients With Favorable Prognosis Inoperable Stage II-IIIA/B Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Induction And Concurrent Hyperfractionated Radiotherapy With Paclitaxel And Carboplatin | PMID 15800308 PMID 18501528 PMID 19858383 |
| 97-05 | Phase II Study of Postoperative Adjuvant Therapy in Patients With Completely Resected Stage II and Stage IIIA Non-Small Cell Lung Cancer | PMID 15908657 |
| 97-01 | Phase III Randomized Trial of Radiation Therapy Alone versus Concurrent Chemotherapy plus Radiation Therapy for Poor-Risk Stage III Non-Small-Cell Lung Carcinoma CLOSED - POOR ACCRUAL | |
| 96-16 | CALGB 9633 A Phase III Study of Adjuvant Chemotherapy After Resection for Patients with T2N0 Stage I Non-small Cell Carcinoma of the Lung | PMID 18809614 |
| 95-11 | CALGB 9334, Intergroup Sclerois of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study | |
| 94-10 94-10 | A Three-Arm Phase III Study of Concomitant Versus Sequential Chemotherapy and Thoracic Radiotherapy for Patients with Locally Advanced Inoperable Non-Small Cell Lung Cancer | ASCO 2003 |
| 94-09 ECOG | ECOG E4592 LABORATORY/CLINICAL CORRELATIVE STUDIES IN NON-SMALL CELL LUNG CANCER. ANCILLARY STUDY TO RTOG 91-05/INT 0115 | |
| 93-11 93-11 | A Phase I-II Dose Escalation Study in Patients with Inoperable Non-Small Cell Lung Cancer | PMID 15667949 |
| 93-09 93-09 | INT 0139 A Phase III Comparison Between Concurrent Chemotherapy Plus Radiotherapy, and Concurrent Chemotherapy plus Radiotherapy followed by Surgical Resection for Stage IIIA (N2) Non-Small Cell Lung Cancer | PMID 19632716 |
| 92-04 | | PMID 12062596 |
| 91-06 Clinicaltrials.gov | Phase I/II Study of Chemotherapy with CDDP/Oral VP-16 plus Radiotherapy in Patients with Locally Advanced, Inoperable non-Small Cell Lung Cancer | PMID 8648357 |
| 91-05 91-05 | INT 0115, ECOG E3590 Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stages II and IIIa Non-Small Cell Lung Cancer | PMID 11071672 |
| 91-03 | PULMONARY FUNCTION OF PATIENTS WITH RADIATION THERAPY FOR NON-SMALL LUNG CANCER | |
| 89-01 | Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2) | PMID 12243809 |
See also: